Akebia Therapeutics Earning Date (AKBA)

USA |NASDAQ |USD

AKBA Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 3, 2022 Jun 2022 $-0.21 - $-0.51
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 3, 2022 Jun 2022 $52.08M - $52.91M

Akebia Therapeutics's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 2022.

AKBA Earnings Date & History Chart

AKBA Earnings & Revenue Forecast

AKBA Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 6 $-0.21 $-0.31 $-0.12
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 7 $-0.82 $-1.23 $-0.51
Dec 2023 6 $-0.64 $-1.17 $-0.29

AKBA Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 4 / 2 $-0.23 $-0.22 $-0.23
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 4 / 2 $-0.95 $-0.81 $-0.77
Dec 2023 1 / 2 $-0.65 $-0.49 $-0.34

AKBA Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 6 $52.08M $42.00M $90.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 7 $198.96M $167.50M $254.00M
Dec 2023 6 $222.67M $185.00M $273.80M

AKBA Earnings Date & Revenue History

AKBA Earnings History

|
Show More
Show More

AKBA Revenue History

|
Show More
Show More

Akebia Therapeutics Next Earnings Date & Report

AKBA Next Earnings Date & Report Preview: Jun 2022 (FQ)

AKBA's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.

According to analysts, the average EPS estimation for Akebia Therapeutics's next quarterly earnings is $-0.21, with a low EPS estimation of $-0.31, and a high estimation of $-0.12.

Over the last 1 month, EPS estimates have seen 4 upward revisions and 2 downward. The EPS 1 month trend is $-0.23, the last 2 month trend is $-0.22, and the 3 month trend is $-0.23.

Based on analysts, the average revenue estimation is $52.08M, with a low revenue estimation of $42.00M, and a high estimation of $90.00M.

Akebia Therapeutics Previous Earnings Dates & Reports

AKBA Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Akebia Therapeutics's previous earnings date was May 9, 2022 for its fiscal quarter ended Mar 31, 2022.

AKBA Previous Earnings Date & Report Recap: Dec 2021 (FY)

Akebia Therapeutics's previous annual earnings date was Mar 1, 2022 for its fiscal year ended Dec 31, 2021.

AKBA's earnings per share (EPS) was $-1.70, missing the consensus analysts forecast of $-1.69 by 0.59% , and higher than the previous year's EPS (Dec 2020) by -11.92%.

Revenues were $213.58M, better than the forecast of $203.94M by 4.73%, and down by -27.68% from previous year's revenue.

The company reported a net income of $-282.84M.

Akebia Therapeutics reported a free cash flow of $-253.02M for its fiscal year, compared to $-110.70M a year ago.

The company ended the fiscal year with $136.05M in total debt, an increase of 33.82% compared to the previous year.